A recent study published in the peer-reviewed journal Military Medical Research shows that the use of cannabidiol (CBD) may be useful in treating chronic Gulf War Illness (GWI).
The study focused on Epidiolex®, a CBD medication that’s FDA-approved, and its effects on cognitive and mood dysfunction, hyperalgesia, and neuroinflammation in a rat model of GWI.
GWI, a condition affecting many veterans of the 1990-1991 Gulf War, is characterized by persistent cognitive and mood impairments, along with chronic neuroinflammation. In this study, rats exposed to chemicals related to GWI, such as pyridostigmine bromide, DEET, and permethrin, and moderate stress were treated with either a vehicle or Epidiolex® over a 16-week period.
Continue reading